Sunnyvale, California-based Rubedo Life Sciences, a biopharmaceutical company, has secured $12 million in seed financing. Khosla Ventures led the round with participation from other investors that included Longevity Fund, Refactor Capital and Shanda.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: